articleTop 1% cited
An extent of resection threshold for newly diagnosed glioblastomas
Journal of neurosurgery · 2011 · Vol. 115(1) · pp. 3–8
Nader Sanai✉Mei‐Yin C. Polley(University of California, San Francisco)Michael W. McDermott(University of California, San Francisco)Andrew T. Parsa(University of California, San Francisco)Mitchel S. Berger(University of California, San Francisco)
Abstract
For patients with newly diagnosed GBMs, aggressive EOR equates to improvement in overall survival, even at the highest levels of resection. Interestingly, subtotal resections as low as 78% also correspond to a survival benefit.
Glioma Diagnosis and TreatmentMeningioma and schwannoma managementBrain Metastases and TreatmentMedicineGlioblastomaSurvival analysisProportional hazards modelSurgeryRecursive partitioningOncologyInternal medicine
MeSH terms
AdultAgedAged, 80 and overAntineoplastic AgentsBrain NeoplasmsCombined Modality TherapyFemaleFollow-Up StudiesGlioblastomaHumansMagnetic Resonance ImagingMaleMiddle AgedPrognosisSurvival Rate
Citations
1,625
FWCI
34.13
field-weighted impact
References
23
Percentile
100%
vs. same field & year
Citations per year
Cited by
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Journal of neurosurgery · 2015 · 633 citations
Clinical practice guidelines for the management of adult diffuse gliomas
Cancer Letters · 2020 · 462 citations
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Cancer Letters · 2016 · 648 citations
References
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
JNCI Journal of the National Cancer Institute · 1994 · 1,124 citations
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
Journal of neurosurgery · 2001 · 3,044 citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
New England Journal of Medicine · 2005 · 21,276 citations
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
New England Journal of Medicine · 2005 · 7,163 citations
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
The Lancet Oncology · 2006 · 3,314 citations
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Neurosurgery · 2008 · 1,295 citations
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
Neurosurgery · 2008 · 1,016 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
